EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ex vivo expansion of lung cancer‐derived disseminated cancer cells from lymph nodes identifies cells associated with metastatic progression

Steffi Treitschke, Kathrin Weidele iD, Adithi Ravikumar Varadarajan, Giancarlo Feliciello, Jens Warfsmann, Sybille Vorbeck, Bernhard Polzer iD, Catherine Botteron, Martin Hoffmann, Vadim Dechand, Tobias Mederer, Florian Weber und 5 weitere

International Journal of Cancer · 2023

DOI: 10.1002/ijc.34658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2023. Verfasst von Steffi Treitschke und 16 weiteren Autor:innen. Beteiligte Einrichtung: Fraunhofer Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany. Hauptthemen laut MEDLINE: Cell Adhesion Molecules, Lung Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cellular basis of the apparent aggressiveness in lung cancer is poorly understood but likely associated with functional or molecular features of disseminated cancer cells (DCCs). DCCs from epithelial cancers are mostly detected by antibodies directed against histogenetic markers such as cytokeratin or EpCAM. It has been argued that marker‐negative metastatic founder cells might escape detection. We therefore used ex vivo sphere formation for functional detection of candidate metastasis founders. We generated cell suspensions from 199 LN samples of 131 lung cancer patients and placed them into non‐adherent cell culture. Sphere formation was associated with detection of DCCs using EpCAM immunocytology and with significantly poorer prognosis. The prognostic impact of sphere formation was strongly associated with high numbers of EpCAM‐positive DCCs and aberrant genotypes of expanded spheres. We also noted sphere formation in patients with no evidence of lymphatic spread, however such spheres showed infrequent expression of signature genes associated with spheres from EpCAM‐positive samples and displayed neither typical lung cancer mutations ( KRAS , TP53 , ERBB1 ) nor copy number variations, but might be linked to disease progression >5 years post curative surgery. We conclude that EpCAM identifies relevant disease‐driving DCCs, that such cells can be expanded for model generation and that further research is needed to clarify the functional and prognostic role of rare EpCAM‐negative sphere forming cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Adhesion MoleculesLung NeoplasmsHumansEpithelial Cell Adhesion MoleculeAntigens, NeoplasmDNA Copy Number VariationsLymph Nodes

Stichwörter der Autor:innen

disseminated cancer cellslung cancermetastatic precursor cellssphere culture

Substanzen

Epithelial Cell Adhesion MoleculeCell Adhesion MoleculesAntigens, Neoplasm

Autor:innen und Institutionen

  • Fraunhofer Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany.
  • Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
  • Institute for Pathology, University of Regensburg, Regensburg, Germany.
  • Department of Thoracic Surgery, University Hospital Regensburg, Regensburg, Germany.

ORCID-Profile: Kathrin Weidele, Bernhard Polzer, Christoph A Klein

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Treitschke, S., Weidele, K., Varadarajan, A. R., Feliciello, G., Warfsmann, J., Vorbeck, S., Polzer, B., Botteron, C., Hoffmann, M., Dechand, V., Mederer, T., Weber, F., Werner-Klein, M., Robold, T., Hofmann, H. S., Werno, C., & Klein, C. A. (2023). Ex vivo expansion of lung cancer‐derived disseminated cancer cells from lymph nodes identifies cells associated with metastatic progression. International Journal of Cancer. https://doi.org/10.1002/ijc.34658

Vancouver

Treitschke S, Weidele K, Varadarajan AR, Feliciello G, Warfsmann J, Vorbeck S, et al. Ex vivo expansion of lung cancer‐derived disseminated cancer cells from lymph nodes identifies cells associated with metastatic progression. International Journal of Cancer. 2023. doi:10.1002/ijc.34658

BibTeX
@article{Treitschke2023,
  author = {Treitschke, Steffi and Weidele, Kathrin and Varadarajan, Adithi Ravikumar and Feliciello, Giancarlo and Warfsmann, Jens and Vorbeck, Sybille and Polzer, Bernhard and Botteron, Catherine and Hoffmann, Martin and Dechand, Vadim and Mederer, Tobias and Weber, Florian and Werner-Klein, Melanie and Robold, Tobias and Hofmann, Hans-Stefan and Werno, Christian and Klein, Christoph A},
  title = {Ex vivo expansion of lung cancer‐derived disseminated cancer cells from lymph nodes identifies cells associated with metastatic progression},
  journal = {International Journal of Cancer},
  year = {2023},
  doi = {10.1002/ijc.34658}
}
Kostenlos starten →